Novavax Market Cap

Novavax has a market cap or net worth of $1.28 billion as of February 21, 2025. Its market cap has increased by 186.52% in one year.

Market Cap

1.28B

Enterprise Value

632.57M

1-Year Change

186.52%

Ranking

#2258

Market Cap Chart

Since December 1, 1998, Novavax's market cap has increased from $25.70M to $1.28B, an increase of 4,880.07%. That is a compound annual growth rate of 16.06%.

Market Cap History

Date	Market Cap	% Change
Feb 20, 2025	1.27B	-1.49%
Dec 31, 2024	1.29B	125.87%
Dec 29, 2023	570.20M	-29.34%
Dec 30, 2022	807.00M	-92.54%
Dec 31, 2021	10.82B	52.38%
Dec 31, 2020	7.10B	6,609.55%
Dec 31, 2019	105.80M	-84.98%
Dec 31, 2018	704.40M	81.13%
Dec 29, 2017	388.90M	13.78%
Dec 30, 2016	341.80M	-84.90%
Dec 31, 2015	2.26B	60.10%
Dec 31, 2014	1.41B	32.47%
Dec 31, 2013	1.07B	281.83%
Dec 31, 2012	279.60M	92.96%
Dec 30, 2011	144.90M	-46.33%
Dec 31, 2010	270.00M	8.56%
Dec 31, 2009	248.70M	90.28%
Dec 31, 2008	130.70M	-36.71%
Dec 31, 2007	206.50M	-18.35%
Dec 29, 2006	252.90M	33.74%
Dec 30, 2005	189.10M	46.70%
Dec 31, 2004	128.90M	-28.82%
Dec 31, 2003	181.10M	182.53%
Dec 31, 2002	64.10M	-80.46%
Dec 31, 2001	328.10M	97.53%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.71B
UnitedHealth Group	429.24B
Novo Nordisk	391.83B
Johnson & Johnson	390.76B
AbbVie	356.74B
Abbott Laboratories	234.01B
AstraZeneca	229.50B
Merck & Co.	226.40B

Market Cap Rankings